1.Ketamine-Propofol Mixture Anesthesia for 85 Children with Congenital Heart Disease Undergoing Cardiac Catheterization
qiu-xia, LI ; en-ming, QING ; fu-shan, XUE
Journal of Applied Clinical Pediatrics 2004;0(09):-
Objective To evaluate the safety and feasibility of ketamine-propofol mixture anesthesia for 85 children with congenital heart disease undergoing cardiac catheterization.Methods Eighty-five children with congenital heart disease undergoing cardiac cathete-rization were randomly divided into ketamine group(K group,n=44)and ketamin-propofol group(KP group,n=41).K group:1 mg?kg-1 ketamine was injected intravenously and then infused at 50 ?g?kg-1?min-1 for anesthesia maintenance.KP group:anesthesia was induced with ketamine 1 mg?kg-1 and propofol 1 mg?kg-1 intravenously,and maintained by continuous infusion of ketamine(16.7 ?g?kg-1?min-1)and propofol(33.3 ?g?kg-1?min-1).Electrocardiogram,blood pressure,pluse,respiratory frequency,saturation of blood oxygen were continously monitored.Results Hemodynamic and respiratory function were stable in both 2 groups.Ketamine consumption in K group was significantly more than that in KP group[(52.1?2.8)?g?kg-1?min-1 vs(25.3?7.3)?g?kg-1?min-1],eye opening time and recovery time were also longer in K group than those in KP group [(50.2?16.5)min vs(40.4?18.3)min].Conclusion The ketamine-propofol mixture was a safe,efficacy anesthesia with excellent recovery in children with congenital heart disease undergoing cardiac catheterization.
2.Radiotherapy of supra-sellar neoplasms.
Fu-quan ZHANG ; Ke HU ; Ming-jie ZHANG ; Jie QIU ; Jiao-chu ZHOU
Chinese Journal of Oncology 2005;27(12):756-757
3.Preliminary studies on Process and Ultramicro-pulverization on pharmacodynamics of Leech
Wen-Hai LU ; Fu-Jun QIU ; Zuo-Ming WANG
China Journal of Chinese Materia Medica 2001;26(4):241-244
Objective:To compare pharmacodynamics of decoction and powder of Leech;To identify effect of pharmacodynamics of Leech with new methods of process and ultrmicro-pulverization.Method:The size of ultramicor-powder of Leech and new method processed Leech is determined by BT-1500 size distributive instrument. It is compared that the pharmacodynamics of Leech decoction and powder as well as ultramicro-powder with new method processed of 1/2 decoction dose by anticoagulation and antithrombus action of mice. The safety of different samples is identified. Result:The pharmacodynamics of samples is as ultramicro-powder of Leech with new method processed>ultrmicro-powder of Leech>powder of Leech>decoction of Leech. Conclusion:The ultramicro-powder of Leech with new method processed has better pharmacodynamic effect and the smell of Leech is improved.
4.Study on inhibitory effect of matrine on cyclooxygenase-2 expression in colon cancer HT-29 cell line.
Jian HUANG ; Ming-jie ZHANG ; Fu-ming QIU
Chinese Journal of Integrated Traditional and Western Medicine 2005;25(3):240-243
OBJECTIVETo explore the effect of matrine on cyclooxygenase-2 (COX-2) expression in colon cancer HT-29 cell line at the level of gene and protein.
METHODSLevels of mRNA and protein expression of COX-2, and its synthesized product prostaglandin E2 (PGE2) of colon cancer HT-29 cell line were detected by RT-PCR, Western-blot, ELISA respectively before and after treatment of matrine in different concentrations.
RESULTSMatrine had inhibitory effect on the mRNA and protein expression of COX-2, and synthesis of PGE2 in colon cancer HT-29 cell line, but had no effect on COX-1. When HT-29 cell line was treated with 2.0 mg/ml of matrine, the inhibitory rate on COX-2 mRNA expression were 100% at 6 hrs and 9 hrs after treatment; the inhibitory rate on PGE2 synthesis was 63.8 % at 9 hrs after treatment; and that on COX-2 protein expression was 48% and 100% 12 hrs and 24 hrs after treatment, respectively.
CONCLUSIONMatrine has selective inhibitory effect on gene transcription, protein expression and functional activity of COX-2 in HT-29 cell line, which is time-dependent and concentration-dependent within certain range of concentration and acting time.
Alkaloids ; pharmacology ; Antineoplastic Agents, Phytogenic ; pharmacology ; Cyclooxygenase 2 ; Dinoprostone ; biosynthesis ; Dose-Response Relationship, Drug ; Drugs, Chinese Herbal ; pharmacology ; Gene Expression Regulation, Enzymologic ; HT29 Cells ; Humans ; Membrane Proteins ; Prostaglandin-Endoperoxide Synthases ; biosynthesis ; genetics ; Quinolizines ; RNA, Messenger ; biosynthesis ; genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Transcription, Genetic
5.Research progress of gammadelta T cell-based immunotherapy.
Fu-ming QIU ; Zhong-peng LI ; Jian HUANG
Journal of Zhejiang University. Medical sciences 2010;39(4):424-429
GammadeltaT cells are considered as linkage between innate and adaptive immune response, which recognize specific antigen without MHC-restriction. Vgamma9Vdelta2T cells, isolated from peripheral blood and tumor tissue, can be activated by non-peptide phosphoantigen through binding to its gammadeltaTCR and proliferate under IL-2 stimulation. It has been shown that Vgamma9Vdelta2T cells possess anticancer activity against several types of tumor in vitro, as well as inhibit the growth of lymphoma, breast cancer and malignant melanoma in vivo. The phase I clinical trial of the application of Vgamma9Vdelta2T cells in treatment of lung cancer, renal cancer and prostate cancer demonstrated promising results. This review summarizes the recent advances in antigen recognition and activation of gammadeltaT cells, and the gammadeltaT cell-based immunotherapy for cancer treatment.
Humans
;
Immunotherapy
;
methods
;
Immunotherapy, Adoptive
;
methods
;
Neoplasms
;
immunology
;
therapy
;
Receptors, Antigen, T-Cell, gamma-delta
;
immunology
;
T-Lymphocyte Subsets
;
immunology
6.Intracranial primary malignant melanoma: report of a case.
Li-qin MA ; Qiu-nian SHI ; Ren ZHOU ; Fu-ming DONG ; Jing-ying YU ; Ru-jun XU
Chinese Journal of Pathology 2011;40(7):494-495
Adolescent
;
Brain Neoplasms
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Female
;
Humans
;
Melanoma
;
metabolism
;
pathology
;
Melanoma-Specific Antigens
;
metabolism
;
Neurilemmoma
;
metabolism
;
pathology
;
S100 Proteins
;
metabolism
;
Vimentin
;
metabolism
7.Comparing controlled hypotension effects of nicardipine used in two different ways in spinal tumoroperation
Qiu-Feng ZHU ; Xiao-Ming YE ; Qiang FU ; Xin-Hua WANG ; Xue-Yin SHI
Academic Journal of Second Military Medical University 2001;22(5):453-455
Objective: To observe the controlled hypotension effects of nicardipine in 2 different ways for spinal tumor operalion. Methods: Twenty-four adult patients, scheduled for selective spinal tumor operation, were randomly divided into 2 groups. In groupⅠ(n=12), the nicardipine was infused at a rate of 10 μg*kg-1*min-1 and the infusion continued until MAP was at the level of 7.33-8.66 kPa, and then the rate was decreased to 1 μg*kg-1*min-1. In Group Ⅱ(n=12), nicardipine was given 0.01-0.02 mg/kg as the load dose, then infused at 1-2 μg*kg-1*min-1. Results: During the period of controlled hypotension, cardiac index(CI) increased significantly, other hemodynamic variables were stable and no hypertension rebound occurred in both groups. Reaching time of target blood pressure in groupⅡ was shorter than that in groupⅠ(P<0.05). The dose required to obtain target blood pressure in group Ⅱwas less than that in group Ⅰ(P<0.05). BP recovery time from discontinuing nicardipine infusion to pre-hypotension level,bleeding volume and transfusion volume were similar between 2 groups(P>0.05).During mass bleeding, serious arrhythmia and oliguria did not occur in any case. Conclusion: Controlled hypotension with nicardipine is rapid, stable and easily controlled without hypertension rebound. Nicardipine has considerable protective effects on heart and kidney during mass bleeding. The method of bolus injection followed with intravenous infusion is more suitable to clinical application.
8.Clinical efficacy and safety analysis of moxifloxacin versus levofloxacin in the treatment of elderly patients with community acquired pneumonia
Shen-Xia REN ; Zhen-Qiu FU ; Ming-Dong WU
The Chinese Journal of Clinical Pharmacology 2015;(18):1803-1805
Objective To explore the clinical efficacy and safety analy-sis of moxifloxacin versus levofloxacin in the treatment of elderly patients with community acquired pneumonia ( CAP ) . Methods Sixty -two elderly patients with CAP were randomly divided into treatment group ( n=32 ) and control group ( n=30 ) .Patients in treatment group were treated with moxifloxacin 400 mg by intravenous transfusion , qd with changes for orally administration 400 mg qd after improvement.Patients in control group were treated with levofloxacin 500 mg by intravenous transfusion , qd with changes for orally administration 100 mg tid after improvement.The total course of administration was less than 2 weeks. The clinical efficacy , total course of administration , pathogenic bacteria clearance rate and safety were evaluated between the two groups . Results The total efficacy was not significant different between the two groups ( P>0.05 ) , but the cure rate in treatment group was significant higher than that in control group ( P<0.05 ) .The total course of drug administration of treatment group was shorter than control group (P<0.05).The pathogenic bacteria clearance rate was 93.75% and 83.33%for treatment and control group respectively which indicated that treatment group was significant higher ( P<0.05 ) .And the drug related
toxicity was not statistically different between the two groups ( P>0.05 ) .Conclusion Both moxifloxacin and levoflo-xacin were effective and safe in the treatment of elderly patients with community acquired pneumonia .And moxifloxacin had higher pathogenic bacteria clearance effects .
9.Human immunodeficiency virus/sexually transmitted infection,risk behavior and sexual networks among men who have sex with men in Taizhou city,Zhejiang province
Wei-Ming ZHU ; Hai-Jiang LIN ; Ya-Fu ZHANG ; Dan-Hong QIU ; Ji-Fu FENG ; Mei-Yang GAO ; Na HE
Chinese Journal of Epidemiology 2008;29(10):994-998
Objective To study the prevalence of human immunodeficiency virus(Hiv),sexually transmitted infection(Sti),risk behavior and the sexual neworks among men who have sex with men (MSM)in Taizhou city,Zhejiang province.Methods cross-sectional Astudy was applied with venue-based sampling in 2 MSM gathering sites in Taizhou.'Informed Consent'principle was applied and MSM were studied through a structured questionnaire.Blood samples were collected from thee who accepted free and confidential HIV/STI counseling and then tested for HIV,syphilis,HCV and HsV-2 antibodies with ELISA.HIV positive sera were certified with western blot.Results 106 MSM were investigated and 97 qualified questionnaires were collected.25.0%(23/92)of these MSM have ever had l female sex partner while 47.8%(44/92)had 2 or more.14.3%(13/91)of them reported having had 1 male partner who had engaged in anal sex and 80.2%(73/91)had 2 or more.22.1%(19/86)of therh had partieipated in group sex but 62.5%(55/88)of them did not always use condom when having analintercourse.15.1%(14/93) of them had l orfll sex partner while 75.3%(70/93)having 2 or more.38.9%(37/95)of them had sex with female sex worker,and 35.5%(33/93)had sex with male-to-male sex worker.15.3%(13/85)0f them had once been male-to-male sex worker themselves.3.9%(3/77)of them were found HIV positive in blood tests,with 24.7%(18/73)positive of syphilis,15.1%(11/73)positive ofHSV-2 but HCV appeared to be negative.46 csses reported their egocentric recognition networks,with mean degree of 5.91(ranging0-10),and mesa density of 0.548(ranging 0.000-1.000).43 sexual networks were identified,with mean degree of 2.70(ranging 0-10),and mean density of 0.246(ranging 0.000-1.000).Conclusion Risk behaviors,such as multiple sex partners,IOW proportion of condom use and commercial sex engagement both with heterosexuals and homosexuals,were extensively existed among MSM in Taizhou,and the prevalence of HIV/STI was relatively high.Their sexual networks seemed complicated but there might be in place of some sukstantiaUy isolated MSM groups with high risk of Hlv/sTl infection.More study should be applied to identify the relationship between scxual networks and HIV/STI transmigsion.
10.Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro.
Jin-Ming WU ; Ju-Sheng LIN ; Na XIE ; Guo-Fu QIU ; Xian-Ming HU
Acta Pharmaceutica Sinica 2005;40(9):825-829
AIMNucleoside analogues have become the most promising candidates of anti-HBV drugs. In this study, beta-L-D4A was synthesized and explored its inhibitiory action against hepatitis B virus (HBV) in 2. 2. 15 cells derived from HepG2 cells transfected with HBV genome.
METHODSbeta-L-D4A was stereo-controlled synthesized from D-glutamic acid, and the structure was identified by IR, 1H NMR and MS. 2. 2. 15 Cells were placed at a density of 5 x 10(4) per well in 12-well tissue culture plates, and treated with various concentrations of beta-L-D4A for 6 days. At the end, medium was processed to obtain virions by a polyethlene glycol precipitation method. At the same time, intracellular DNA was also extracted and digested with Hind III. Both of the above DNA were subjected to Southern blot, hybridized with a 32P-labeled HBV probe and autoradiographed. The intensity of the autoradiographic bands was quantitated by densitometric scans of computer and EC50 was calculated. 2. 2. 15 cells were also seeded in 24-well tissue culture plates, and cytotoxicity with different concentrations was examined by MTT method. IC50 was calculated.
RESULTSThe synthesized compound structure conformed with beta-L-D4A; Autoradiographic bands showed similar for supernatant and intracellular HBV DNA. Episomal HBV DNA was inhibited in a dose-dependent manner. EC50 0.2 micromol x L(-1). The experiment of cytotoxicity gained IC50 200 micromol x L(-10.
CONCLUSIONbeta-L-D4A has been synthesized successfully. beta-L-D4A possessed potent inhibitory effect on replication of HBV in vitro with low cytotoxicity, TI value was 1 000. It is expected to be developed clinically into a new anti-HBV drug.
Antiviral Agents ; chemical synthesis ; chemistry ; pharmacology ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; DNA Replication ; drug effects ; DNA, Viral ; drug effects ; Dideoxyadenosine ; analogs & derivatives ; chemical synthesis ; chemistry ; pharmacology ; Genome, Viral ; Hepatitis B virus ; drug effects ; genetics ; physiology ; Humans ; Liver Neoplasms ; pathology ; Transfection ; Virus Replication ; drug effects